These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25374989)

  • 1. Azithromycin and the risk of cardiovascular complications.
    Maisch NM; Kochupurackal JG; Sin J
    J Pharm Pract; 2014 Oct; 27(5):496-500. PubMed ID: 25374989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin-induced proarrhythmia and cardiovascular death.
    Howard PA
    Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-based approach to evaluating azithromycin use and cardiovascular risks.
    Wong E; Nguyen TV
    Consult Pharm; 2014 Jan; 29(1):47-52. PubMed ID: 24413014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
    Chou HW; Wang JL; Chang CH; Lai CL; Lai MS; Chan KA
    Clin Infect Dis; 2015 Feb; 60(4):566-77. PubMed ID: 25409476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is cardiovascular risk a concern when prescribing azithromycin?
    Sutton SS
    JAAPA; 2017 Jan; 30(1):11-13. PubMed ID: 28033168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center.
    Lee RA; Guyton A; Kunz D; Cutter GR; Hoesley CJ
    J Hosp Med; 2016 Jan; 11(1):15-20. PubMed ID: 26287278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsades de pointes induced by the concomitant use of ivabradine and azithromycin: an unexpected dangerous interaction.
    Cocco G; Jerie P
    Cardiovasc Toxicol; 2015 Jan; 15(1):104-6. PubMed ID: 25158669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of azithromycin and death from cardiovascular causes.
    Svanström H; Pasternak B; Hviid A
    N Engl J Med; 2013 May; 368(18):1704-12. PubMed ID: 23635050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin before and after the 2012 FDA Warning on the Risk of Potentially Fatal Heart Rhythms.
    Patel H; Calip GS; DiDomenico RJ; Schumock GT; Suda KJ; Lee TA
    Pharmacotherapy; 2020 Feb; 40(2):107-115. PubMed ID: 31867748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin.
    Patel H; Calip GS; DiDomenico RJ; Schumock GT; Suda KJ; Lee TA
    JAMA Netw Open; 2020 Sep; 3(9):e2016864. PubMed ID: 32930780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of QT-interval prolongation precipitated by azithromycin.
    Matsunaga N; Oki Y; Prigollini A
    N Z Med J; 2003 Nov; 116(1185):U666. PubMed ID: 14615808
    [No Abstract]   [Full Text] [Related]  

  • 12. Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia.
    Goldstein LH; Gabin A; Fawaz A; Freedberg NA; Schwartz N; Elias M; Saliba W
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1042-8. PubMed ID: 26238864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin-induced torsade de pointes.
    Huang BH; Wu CH; Hsia CP; Yin Chen C
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1579-82. PubMed ID: 18070319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death.
    Rao GA; Mann JR; Shoaibi A; Bennett CL; Nahhas G; Sutton SS; Jacob S; Strayer SM
    Ann Fam Med; 2014; 12(2):121-7. PubMed ID: 24615307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block.
    Thomsen MB; Beekman JD; Attevelt NJ; Takahara A; Sugiyama A; Chiba K; Vos MA
    Br J Pharmacol; 2006 Dec; 149(8):1039-48. PubMed ID: 17088870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin and the risk of cardiovascular death.
    Ray WA; Murray KT; Hall K; Arbogast PG; Stein CM
    N Engl J Med; 2012 May; 366(20):1881-90. PubMed ID: 22591294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly.
    Taylor SP; Sellers E; Taylor BT
    Am J Med; 2015 Dec; 128(12):1362.e1-6. PubMed ID: 26291905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmias associated with fluoroquinolone therapy.
    Falagas ME; Rafailidis PI; Rosmarakis ES
    Int J Antimicrob Agents; 2007 Apr; 29(4):374-9. PubMed ID: 17241772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolides use and the risk of sudden cardiac death.
    Li X; Wang M; Liu G; Zhou L; Wang Z; Li C
    Expert Rev Anti Infect Ther; 2016 Jun; 14(6):535-7. PubMed ID: 27086751
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions.
    Ehrlich H; Elkbuli A
    Am J Emerg Med; 2021 Oct; 48():363-364. PubMed ID: 33551245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.